Autolus Therapeutics plc (NASDAQ:AUTL) experienced a significant decrease in short interest during the month of August, according to the latest ...
In its most recent Form 13F filing with the Securities and Exchange Commission (SEC), ProShare Advisors LLC has reported an ...
Public Sector Pension Investment Board has significantly increased its stake in The Beauty Health Company during the first quarter of ...
ExodusPoint Capital Management LP has recently increased its stake in Autolus Therapeutics plc, a clinical-stage biopharmaceutical company specializing in the ...
On September 5, 2023, Autolus Therapeutics made an exciting announcement regarding the publication of data from the AUTO1/22 Phase 1 ...
Autolus Therapeutics plc (NASDAQ:AUTL) experienced a significant decline in short interest during the month of August, according to recent data. ...
August 22, 2023 - MAI Capital Management, a renowned institutional investor, has recently reported a reduction in its stake in ...
Autolus Therapeutics plc (NASDAQ:AUTL) experienced a 3.1% increase in its share price during mid-day trading on Friday, following Truist Financial's ...
Autolus Therapeutics' groundbreaking therapy, Obe-Cel, is revolutionizing the field of CD19 CAR T cell treatments. Unlike its predecessors, Obe-Cel addresses ...
Autolus Therapeutics has experienced a surge in its share value as Truist Securities reaffirmed its positive stance on the stock ...